Literature DB >> 3754893

An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.

K Yamaoka, H Tanaka, K Okumura, M Yasuhara, R Hori.   

Abstract

An analysis program MULTI(ELS) was developed for population pharmacokinetics on a microcomputer. The program based on the extended least squares (ELS) is written in the Microsoft minimum BASIC command alone. ELS simultaneously estimates not only the population pharmacokinetic parameters but also the variances of inter-individual variabilities around the population parameters and of intra-individual variabilities for the plural time courses, whereas the ordinary least squares estimates the pharmacokinetic parameters of each time course. Two least squares algorithms (i.e. quasi-Newton and simplex methods) are provided in MULTI(ELS). MULTI(ELS) was compared with NONMEM (Version I, Level 3) developed by Sheiner and Beal for several time course data. It was shown that MULTI(ELS) gave the same results as NONMEM. MULTI(ELS) calculates the Akaike's information criterion (AIC) for the extended least squares. It was also shown that the AIC is effective in comparing the population characteristics of time courses in a group with those in another group and in verifying the model structures of population means, inter-individual variations and intra-individual variations.

Mesh:

Substances:

Year:  1986        PMID: 3754893

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  8 in total

1.  Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

Authors:  A Hisaka; Y Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.

Authors:  Hiroyuki Kusuhara; Hidetoshi Furuie; Akihiro Inano; Akihiro Sunagawa; Saiko Yamada; Chunyong Wu; Shinya Fukizawa; Nozomi Morimoto; Ichiro Ieiri; Mariko Morishita; Kiminobu Sumita; Hiroshi Mayahara; Takuya Fujita; Kazuya Maeda; Yuichi Sugiyama
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier.

Authors:  Masanori Tachikawa; Koji Murakami; Pamela M Martin; Ken-ichi Hosoya; Vadivel Ganapathy
Journal:  Microvasc Res       Date:  2011-06-29       Impact factor: 3.514

4.  Statistics or pharmacokinetics?

Authors:  V K Piotrovskij
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

5.  Population pharmacokinetics of phenytoin in Singapore Chinese.

Authors:  E Chan; T Y Ti; H S Lee
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.

Authors:  Sail Urien; François Lokiec
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

7.  Population pharmacokinetics of imipramine in children.

Authors:  M Tamayo; M M Fernández de Gatta; M J García; A Domínguez-Gil
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.

Authors:  Y Ando; H Minami; H Saka; M Ando; S Sakai; K Shimokata
Journal:  Jpn J Cancer Res       Date:  1996-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.